X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8560) 8560
Newsletter (176) 176
Book Chapter (28) 28
Magazine Article (28) 28
Dissertation (19) 19
Publication (8) 8
Conference Proceeding (4) 4
Newspaper Article (4) 4
Web Resource (4) 4
Book Review (3) 3
Transcript (3) 3
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5711) 5711
science & technology (5138) 5138
life sciences & biomedicine (4994) 4994
clarithromycin (3901) 3901
male (3336) 3336
female (3206) 3206
clarithromycin - therapeutic use (3000) 3000
anti-bacterial agents - therapeutic use (2411) 2411
adult (2306) 2306
middle aged (2296) 2296
helicobacter pylori (2266) 2266
helicobacter infections - drug therapy (2255) 2255
drug therapy, combination (1846) 1846
clarithromycin - pharmacology (1706) 1706
aged (1634) 1634
pharmacology & pharmacy (1599) 1599
clarithromycin - administration & dosage (1598) 1598
anti-bacterial agents - pharmacology (1462) 1462
helicobacter pylori - drug effects (1389) 1389
microbiology (1363) 1363
treatment outcome (1309) 1309
gastroenterology & hepatology (1280) 1280
anti-bacterial agents - administration & dosage (1146) 1146
microbial sensitivity tests (1093) 1093
amoxicillin - therapeutic use (1028) 1028
infectious diseases (901) 901
adolescent (827) 827
helicobacter infections - microbiology (793) 793
antibiotics (767) 767
clarithromycin - adverse effects (749) 749
animals (713) 713
omeprazole - therapeutic use (691) 691
amoxicillin - administration & dosage (677) 677
anti-ulcer agents - therapeutic use (666) 666
amoxicillin (644) 644
anti-bacterial agents - adverse effects (620) 620
helicobacter pylori - isolation & purification (614) 614
drug resistance, bacterial (589) 589
prospective studies (547) 547
child (536) 536
aged, 80 and over (522) 522
abridged index medicus (510) 510
general & internal medicine (509) 509
metronidazole - therapeutic use (489) 489
metronidazole (488) 488
drug administration schedule (479) 479
health aspects (478) 478
omeprazole - administration & dosage (471) 471
medicine, general & internal (453) 453
helicobacter infections (429) 429
lansoprazole (426) 426
2-pyridinylmethylsulfinylbenzimidazoles (420) 420
infections (420) 420
azithromycin (412) 412
research (406) 406
drug therapy (404) 404
omeprazole - analogs & derivatives (399) 399
anti-ulcer agents - administration & dosage (398) 398
bacterial infections and mycoses (398) 398
helicobacter infections - complications (393) 393
time factors (391) 391
helicobacter pylori - genetics (384) 384
drug resistance, microbial (375) 375
proton pump inhibitors (374) 374
care and treatment (369) 369
drug resistance (366) 366
erythromycin - pharmacology (361) 361
drug interactions (360) 360
young adult (356) 356
levofloxacin (355) 355
helicobacter infections - diagnosis (352) 352
child, preschool (351) 351
biopsy (349) 349
analysis (341) 341
erythromycin (339) 339
metronidazole - administration & dosage (338) 338
immunology (324) 324
double-blind method (321) 321
mycobacterium infections, nontuberculous - drug therapy (313) 313
macrolides (305) 305
drug resistance in microorganisms (304) 304
research article (301) 301
retrospective studies (298) 298
mice (297) 297
follow-up studies (296) 296
antibiotic resistance (288) 288
clarithromycin - pharmacokinetics (288) 288
metronidazole - pharmacology (283) 283
risk factors (280) 280
amoxicillin - pharmacology (278) 278
polymerase chain reaction (278) 278
drug therapy, combination - therapeutic use (273) 273
eradication (269) 269
dose-response relationship, drug (268) 268
peptic ulcer - drug therapy (268) 268
proton pump inhibitors - therapeutic use (264) 264
administration, oral (259) 259
helicobacter infections - epidemiology (256) 256
duodenal ulcer - drug therapy (253) 253
antibacterial agents (252) 252
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7981) 7981
Japanese (521) 521
Spanish (205) 205
German (125) 125
French (124) 124
Chinese (84) 84
Russian (74) 74
Korean (64) 64
Portuguese (58) 58
Italian (32) 32
Polish (31) 31
Turkish (25) 25
Dutch (17) 17
Hungarian (16) 16
Czech (12) 12
Danish (5) 5
Swedish (5) 5
Ukrainian (4) 4
Hebrew (3) 3
Norwegian (2) 2
Romanian (2) 2
Bulgarian (1) 1
Persian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 51 - 69.e14
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2007, Volume 132, Issue 7, pp. 2313 - 2319
Journal Article
Gut, ISSN 0017-5749, 11/2010, Volume 59, Issue 11, pp. 1465 - 1470
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 9/2018, Volume 74, Issue 9, pp. 1149 - 1157
Ilaprazole, the latest proton pump inhibitor, can be used with clarithromycin and amoxicillin as a triple therapy regimen for eradicating Helicobacter pylori.... 
Clarithromycin | Biomedicine | Amoxicillin | Drug interaction | Ilaprazole | Pharmacology/Toxicology | Pharmacokinetics | Proton pump inhibitor | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Anti-Bacterial Agents - blood | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Healthy Volunteers | Clarithromycin - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - pharmacokinetics | Patient Safety | Clarithromycin - administration & dosage | Adult | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Proton Pump Inhibitors - blood | Drug Therapy, Combination | Republic of Korea | Proton Pump Inhibitors - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | Risk Assessment | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Amoxicillin - blood | Amoxicillin - pharmacokinetics | Cross-Over Studies | Proton Pump Inhibitors - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Amoxicillin - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | 2-Pyridinylmethylsulfinylbenzimidazoles - blood | Helicobacter Infections - microbiology | Complications and side effects | Dosage and administration | Safety and security measures | Drug interactions | Confidence intervals | Therapy | Randomization | Statistical analysis | Pharmacology | Safety | Index Medicus | Pharmacokinetics and Disposition
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 09/2013, Volume 76, Issue 3, pp. 455 - 466
Aims The anticoagulant rivaroxaban is an oral, direct Factor Xa inhibitor for the management of thromboembolic disorders. Metabolism and excretion involve... 
P‐glycoprotein | rivaroxaban | drug interactions | cytochrome P450 | healthy subjects | P-glycoprotein | Rivaroxaban | Healthy subjects | Cytochrome P450 | Drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Anticoagulants - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Erythromycin - pharmacology | Ketoconazole - administration & dosage | Humans | Middle Aged | Cytochrome P-450 Enzyme System - metabolism | Midazolam - administration & dosage | Substrate Specificity | Metabolic Clearance Rate | Thiophenes - administration & dosage | Ketoconazole - pharmacology | Enzyme Inhibitors - administration & dosage | Young Adult | Drug Interactions | Enzyme Inhibitors - pharmacokinetics | Clarithromycin - pharmacokinetics | Clarithromycin - administration & dosage | Adult | Morpholines - administration & dosage | Enzyme Inhibitors - pharmacology | Ketoconazole - pharmacokinetics | Midazolam - pharmacokinetics | Cytochrome P-450 CYP3A - administration & dosage | Erythromycin - administration & dosage | ATP Binding Cassette Transporter, Subfamily B, Member 1 - antagonists & inhibitors | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Thiophenes - pharmacokinetics | Erythromycin - pharmacokinetics | Cytochrome P-450 CYP3A - metabolism | Adolescent | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Clarithromycin - pharmacology | Midazolam - pharmacology | Ketoconazole | Protease inhibitors | Fluconazole | Proteases | Cytochrome P-450 | Dosage and administration | Anticoagulants (Medicine) | Erythromycin | Thromboembolism | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 6 - 30
Journal Article